1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid has been researched along with Stomach Neoplasms in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 4 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Arslan, E; Beyhan, E; Çermik, TF; Ergül, N; Erol Fenercioğlu, Ö | 1 |
| Cox, T; Leeuwenkamp, O; O'Connell, M; Palimaka, S; Reed, N | 1 |
| Cui, XM; Du, T; Hu, RH; Jiang, JJ; Jiang, XH; Wang, HY; Zhang, S; Zhao, J; Zhong, L | 1 |
| Colcher, DM; Fong, Y; Frankel, P; Hernandez, MC; Kim, J; Mortimer, JE; Park, J; Poku, E; Shively, J; Wong, J; Woo, Y; Yamauchi, D; Yazaki, P | 1 |
| Areces, L; Bussolati, G; Cassoni, P; Chini, B; Chinol, M; Manning, M; Marrocco, T; Paganelli, G; Papi, S; Reversi, A | 1 |
| Courtenay-Luck, NS; Epenetos, AA; Gooden, CS; Kosmas, C; McCall, MJ; Meares, CF; Snook, D | 1 |
1 trial(s) available for 1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid and Stomach Neoplasms
| Article | Year |
|---|---|
Development of humoral immune responses against a macrocyclic chelating agent (DOTA) in cancer patients receiving radioimmunoconjugates for imaging and therapy.
Topics: Aged; Antibodies; Antibodies, Monoclonal; Antibody Formation; Breast; Breast Neoplasms; Chelating Agents; Drug Evaluation; Female; Heterocyclic Compounds; Heterocyclic Compounds, 1-Ring; Humans; Indium Radioisotopes; Male; Middle Aged; Neoplasm Staging; Neoplasms; Ovarian Neoplasms; Radioimmunotherapy; Radionuclide Imaging; Stomach Neoplasms; Testicular Neoplasms; Yttrium Radioisotopes | 1992 |
5 other study(ies) available for 1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid and Stomach Neoplasms
| Article | Year |
|---|---|
Intense 68Ga-DOTA-FAPI-04 Uptake in Diffuse Sclerotic Skeletal Metastases of Gastric Cancer.
Topics: Fluorodeoxyglucose F18; Heterocyclic Compounds, 1-Ring; Humans; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Quinolines; Stomach Neoplasms | 2022 |
Real-world comparison of healthcare resource utilization and costs of [
Topics: Cohort Studies; Heterocyclic Compounds, 1-Ring; Hospitals; Humans; Intestinal Neoplasms; Neuroendocrine Tumors; Octreotide; Pancreatic Neoplasms; Patient Acceptance of Health Care; Somatostatin; Stomach Neoplasms | 2022 |
Comparison of [
Topics: Aged; Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Magnetic Resonance Imaging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Stomach Neoplasms | 2023 |
Pilot study of HER2 targeted 64 Cu-DOTA-tagged PET imaging in gastric cancer patients.
Topics: Breast Neoplasms; Female; Humans; Pilot Projects; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Receptor, ErbB-2; Stomach Neoplasms; Trastuzumab | 2023 |
Improved radiotracing of oxytocin receptor-expressing tumours using the new [111In]-DOTA-Lys8-deamino-vasotocin analogue.
Topics: Animals; Breast Neoplasms; Carcinoma; Chelating Agents; COS Cells; Glioblastoma; Heterocyclic Compounds, 1-Ring; Humans; Indium Radioisotopes; Isotope Labeling; Mice; Neoplasms; Oxytocin; Protein Binding; Radioactive Tracers; Radioligand Assay; Radionuclide Imaging; Radiopharmaceuticals; Receptors, Oxytocin; Sensitivity and Specificity; Stomach Neoplasms; Tissue Distribution; Transfection; Tumor Cells, Cultured; Vasotocin | 2003 |